Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors

Published:2021-10-14 Issue:21 Volume:10 Page:7457-7465
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Gulati Nicholas¹^ORCID,Celen Arda¹^ORCID,Johannet Paul¹,Mehnert Janice M.²,Weber Jeffrey²,Krogsgaard Michelle³,Osman Iman¹^ORCID,Zhong Judy⁴^ORCID

Affiliation:

1. The Ronald O. Perelman Department of Dermatology New York University Grossman School of Medicine New York NY USA

2. Department of Medicine New York University Grossman School of Medicine New York NY USA

3. Department of Pathology New York University Grossman School of Medicine New York NY USA

4. Department of Population Health New York University Grossman School of Medicine New York NY USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4239

Reference18 articles.

1. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

2. Immunotherapy to treat malignancy in patients with pre-existing autoimmunity

3. Cancer risk in immune-mediated inflammatory diseases (IMID)

4. Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data

5. Immunotherapy in patients with autoimmune disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease;European Journal of Cancer;2024-08

3. Refining mutanome-based individualised immunotherapy of melanoma using artificial intelligence;European Journal of Medical Research;2024-01-05

4. Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment;International Journal of Biological Sciences;2024